Literature DB >> 34785945

A Feasibility Study on Using Single-Photon Emission Computed Tomography Pulmonary Perfusion/Ventilation Imaging for the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension and Patient Risk Assessment.

Rong-Zheng Ma1, Ping-Ping Han1, Xin-Cao Tao2, Huan Li1, Ling Wang1, Zhen-Guo Zhai2, Li-Ping Fu1.   

Abstract

OBJECTIVE: The study is designed to evaluate the diagnostic ability of single-photon emission computed tomography (SPECT) pulmonary ventilation/perfusion (V/Q) imaging in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and investigate its feasibility in assessing patient risk.
METHODS: A total of 83 patients suspected of having CTEPH who received V/Q tomography were retrospectively analyzed. The consistency between SPECT V/Q imaging and pulmonary angiography was compared to investigate the correlation between the percentage of pulmonary perfusion defect score (PPDs%) and the hemodynamic indices. Patients were grouped according to the pulmonary arterial hypertension risk stratification, and the V/Q imaging results were compared between different groups.
RESULTS: For the 1494 pulmonary segments of the 83 patients, the sensitivity, specificity, and accuracy of identifying pulmonary segments with defects using V/Q imaging was 87.05%, 82.78% (668/807), and 84.74% (1266/1494), respectively. The average PPDs% (58.8 ± 12.6%) was positively correlated with the mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance (PVR), and right ventricular pressure (RVP; r =0.316, 0.318, and 0.432, respectively; P < 0.05) and negatively correlated with the six-minute walk distance (6MWD; r = -0.309; P < 0.05). There were 37 patients in the low-risk group and 46 in the medium-high-risk group. The number of pulmonary segments with perfusion defects (NPSPDs) and PPDs% were higher in the medium-high risk than in the low-risk group (t = -6.721, -5.032; P < 0.05). In the low- and medium-high-risk groups, the cut-off values for the NPSPDs (7.2 ± 2.1 and 10.2 ± 2.0) and PPDs% (51.9 ± 11.1% and 64.3 ± 11.1%,) were 8.5 and 61.25%, respectively.
CONCLUSION: SPECT V/Q imaging achieved an accurate diagnosis of CTEPH. The semi-quantitative analysis index (PPDs%) was correlated with the hemodynamic indices and 6MWD. SPECT V/Q could be used for the preoperative risk assessment of patients with CTEPH.
© 2021 Ma et al.

Entities:  

Keywords:  99mTc-MAA; pulmonary artery; pulmonary hypertension; pulmonary perfusion/ventilation imaging; risk stratification; thrombosis

Year:  2021        PMID: 34785945      PMCID: PMC8591112          DOI: 10.2147/IJGM.S335051

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  23 in total

1.  Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Authors:  Athénaïs Boucly; Jason Weatherald; Laurent Savale; Xavier Jaïs; Vincent Cottin; Grégoire Prevot; François Picard; Pascal de Groote; Mitja Jevnikar; Emmanuel Bergot; Ari Chaouat; Céline Chabanne; Arnaud Bourdin; Florence Parent; David Montani; Gérald Simonneau; Marc Humbert; Olivier Sitbon
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

Review 2.  V/Q SPECT imaging of acute pulmonary embolus - a practical perspective.

Authors:  I J Laurence; S L Redman; A J G Corrigan; R N J Graham
Journal:  Clin Radiol       Date:  2012-05-28       Impact factor: 2.350

3.  Chronic thromboembolic pulmonary hypertension: evaluation of V/Q SPECT/CT and V/Q Quotient SPECT findings with postoperative results of pulmonary endarterectomy.

Authors:  Salih Ozguven; Tunc Ones; Emine Bozkurtlar; Mehmed Yanartas; Serpil Tas; Sabahat Inanir; Halil Turgut Turoglu; Tanju Yusuf Erdil; Bedrettin Yildizeli
Journal:  Nucl Med Commun       Date:  2021-04-01       Impact factor: 1.690

4.  Quantitation of Perfused Lung Volume Using Hybrid SPECT/CT Allows Refining the Assessment of Lung Perfusion and Estimating Disease Extent in Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Thorsten Derlin; Catharina Kelting; Katja Hueper; Desiree Weiberg; Katrin Meyer; Karen M Olsson; James T Thackeray; Tobias Welte; Frank M Bengel; Marius M Hoeper
Journal:  Clin Nucl Med       Date:  2018-06       Impact factor: 7.794

5.  The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure.

Authors:  Rebecca Boxer; Alison Kleppinger; Amir Ahmad; Kristin Annis; David Hager; Anne Kenny
Journal:  Congest Heart Fail       Date:  2010 Sep-Oct

Review 6.  Chronic thromboembolic pulmonary hypertension.

Authors:  P Dartevelle; E Fadel; S Mussot; A Chapelier; P Hervé; M de Perrot; J Cerrina; F L Ladurie; D Lehouerou; M Humbert; O Sitbon; G Simonneau
Journal:  Eur Respir J       Date:  2004-04       Impact factor: 16.671

7.  Survival in primary pulmonary hypertension. Validation of a prognostic equation.

Authors:  J Sandoval; O Bauerle; A Palomar; A Gómez; M L Martínez-Guerra; M Beltrán; M L Guerrero
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

8.  Comparative assessment of qualitative and quantitative perfusion with dual-energy CT and planar and SPECT-CT V/Q scanning in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Rahul D Renapurkar; Michael A Bolen; Sankaran Shrikanthan; Jennifer Bullen; Wadih Karim; Andrew Primak; Gustavo A Heresi
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

9.  EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond.

Authors:  Marika Bajc; Carl Schümichen; Thomas Grüning; Ari Lindqvist; Pierre-Yves Le Roux; Adriano Alatri; Ralf W Bauer; Mirza Dilic; Brian Neilly; Hein J Verberne; Roberto C Delgado Bolton; Bjorn Jonson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-13       Impact factor: 9.236

10.  Correlation Between Perfusion Abnormalities Extent in Ventilation/Perfusion SPECT/CT with Hemodynamic Parameters in Patients with Chronic Thromboembolic Pulmonary Hypertension

Authors:  Salih Özgüven; Selin Kesim; Kevser Öksüzoğlu; Mehmed Yanartaş; Serpil Taş; Feyza Şen; Tunç Öneş; Sabahat İnanır; Halil Turgut Turoğlu; Bülent Mutlu; Tanju Yusuf Erdil; Bedrettin Yıldızeli
Journal:  Mol Imaging Radionucl Ther       Date:  2021-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.